Nateglinide is an N-acyl-D-phenylalanine derivative that functions as an orally administered, rapidly absorbed, short-acting insulinotropic agent. It is used as a hypoglycemic agent and an inhibitor of dipeptidyl-peptidase IV, primarily in the manufacturing of pharmaceutical products for type 2 diabetes mellitus.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 105816-06-6
Nateglinide
active pharmaceutical ingredient
D-Phenylalanyl Nateglinide
research compound
Nateglinide Methyl Ester
intermediate for nateglinide synthesis
Tropisetron hydrochloride
active pharmaceutical ingredient
Doxycycline hydrochloride
active pharmaceutical ingredient
CLINAFLOXACIN
investigational fluoroquinolone antibiotic
Clodronic Acid
Bone resorption inhibitor
Ent-Nateglinide
active pharmaceutical ingredient
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
OELFLUMRDSZNSF-OFLPRAFFSA-N
CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O